Many patients in these groups become refractory to NO and NO-releasing agents because the endothelium and underlying smooth no longer respond at the molecular level.
And I'm quite sure that the reason for that lack of response is not because the NO isn't being delivered in a "pulsatile" fashion.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.